The use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders

Details for Australian Patent Application No. 2001275280 (hide)

Owner Teva Pharmaceutical Industries Ltd.

Inventors Yong, V. Wee; Chabot, Sophie

Agent Davies Collison Cave

Pub. Number AU-B-2001275280

PCT Pub. Number WO01/93828

Priority 09587523 05.06.00 US

Filing date 5 June 2001

Wipo publication date 17 December 2001

Acceptance publication date 16 March 2006

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61F 9/02 (2006.01) Treatment or protection of the eyes or ears - Goggles

A61F 13/00 (2006.01) Bandages, dressings or absorbent pads

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

16 March 2006 Application Accepted

  Published as AU-B-2001275280

13 July 2006 Standard Patent Sealed

24 January 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001275281-A device for delivering a therapeutic dosage

2001275279-Caspase inhibitors and uses thereof